Advanced Filters
noise

One or multiple investigational sites, Spain Clinical Trials

A listing of One or multiple investigational sites, Spain clinical trials actively recruiting patients volunteers.

Found 64,783 clinical trials
J Jesmin Sultana, MBBS

RINEW Randomized Controlled Trial 7-year Follow-up

This study is designed to evaluate the impact of the RINEW multicomponent early child development intervention on child development and risk factors for poor child development in middle childhood. This study is a follow-up assessment of the children and primary caregivers enrolled in the RINEW cluster randomized controlled trial approximately …

6 - 9 years of age All Phase N/A

StrokeNet Thrombectomy Endovascular Platform

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

18 years of age All Phase N/A
P Piergiorgio Muriana, MD

Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.

The study is an interventional pilot study. The study is designed to be monocentric and it presents additional procedues.

18 years of age All Phase N/A
A Alejandra Jauregui de la Mota, PhD

Place Activation in Urban Peripheries: the 'Comunidades y Espacios Activos" Project (CEA)

This study will use a Hybrid III Cluster-Randomized Controlled Trial to test an 'active dissemination and implementation' intervention in peripheral urban neighborhoods, designed to accelerate the uptake of evidence-based place-based activations that are known to be effective in increasing physical activity among local residents. The study will use a parallel …

18 years of age All Phase N/A
A Adrian Regli

A Platform Trial for Gram Negative Bloodstream Infections

BALANCE+ is a perpetual multiple domain randomized controlled platform trial to evaluate various treatment strategies for Gram-negative bloodstream infections (GN BSIs). Each domain addresses critical questions in the management of GN BSIs, aiming to refine treatment strategies, enhance patient outcomes, and reduce antimicrobial resistance. The initial vanguard pilot RCT (NCT05893147) …

- 130 years of age All Phase N/A
D Dominic Foo

Evaluation of a Program for Routine Implementation of Symptom Distress Screening and Referral in Cancer Care

This study proposes to evaluate the process and outcome of an implementation program designed to implement nurse-led symptom distress screening and referral into routine cancer care clinics. Specifically, using a stepped-wedge cluster randomized controlled trial, This study aim to test if a systematic symptom distress screening program increases the proportion …

18 years of age All Phase N/A

Modified Dosage for Moderate Acute Malnutrition (MODAM-MAM)

Protocols for the community-based management of acute malnutrition (CMAM) have not changed significantly for more than 20 years, with relatively complex treatment protocols and persistent supply chain challenges that have limited overall program coverage, leaving millions of malnourished children without care annually. The overarching goal of this research project is …

6 - 59 years of age All Phase N/A
m mohamed G. Zeinhom, MD

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 200mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.

18 - 75 years of age All Phase 3

Brief Behavioural Economic Intervention for Smoking Cessation

The goal of this clinical trial is to test the effectiveness of brief behavioural economic intervention in promoting smoking cessation among smokers in the community.

18 years of age All Phase N/A
H Honglei Chen, MD

Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection

Eradication of HP can significantly improve and reduce HP-related diseases. A 10-14 day quadruple regimen containing bismuth as first-line treatment, achieving an eradication rate of more than 85%. However, some disadvantages of these quadruple regimens, such as severe adverse reactions, high medical costs and low compliance, prevent their application in …

18 - 75 years of age All Phase 3

Simplify language using AI